BusinessCyclacel’s Novel PLK1 Inhibitor, CYC140, Demonstrates Therapeutic Potential in Esophageal Cancer and Acute LeukemiaBy Nasdaq OMXDec 1, 2016, 12:00 PM UTC
BusinessThe Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved Cardiac Function in Patients With Chronic Heart FailureBy Nasdaq OMXNov 30, 2016, 11:30 PM UTC
BusinessNovavax to Participate in the Citi 2016 Global Healthcare ConferenceBy Nasdaq OMXNov 30, 2016, 9:05 PM UTC
BusinessTonix Pharmaceuticals to Present at 9th Annual LD Micro Main Event Investor ConferenceBy Nasdaq OMXNov 30, 2016, 12:00 PM UTC
BusinessAchillion Announces Initiation of Patient Dosing by Janssen in a Global, Short Treatment-Duration Phase 2b Study of JNJ-4178 in Chronic HCVBy Nasdaq OMXNov 30, 2016, 11:05 AM UTC
BusinessAXIM® Biotech Files IP Application on Propietary Method to Extract High-Purity THCBy Nasdaq OMXNov 29, 2016, 2:01 PM UTC
BusinessAXIM® Biotech Files IP Application on Propietary Method to Extract High-Purity THCBy Nasdaq OMXNov 29, 2016, 2:01 PM UTC
BusinessKalVista Pharmaceuticals Appoints Edward P. Feener, Ph.D. as Chief Scientific OfficerBy Nasdaq OMXNov 29, 2016, 12:30 PM UTC
